Barclays »

Oncolytics Biotech shares owned by Barclays

Quarter-by-quarter ownership of Oncolytics Biotech (ONCY) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Oncolytics Biotech

Tip: Access up to 7 years of quarterly data

All positions including Oncolytics Biotech held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncolytics Biotech by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.0k 1.2k 1.67
2023-09-30 $2.0k 800 2.50

More positions owned by Barclays

Invesco Qqq Tr Fund (QQQ)
Microsoft Corp Opt Put Option (MSFT)
Ishares Tr Fund (IWM)
Apple Opt Call Option (AAPL)
SPDR S&ampP 500 ETF TR Fund (SPY)
Nvidia Corporation Opt Call Option (NVDA)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Facebook Inc cl a (META)
Tesla Motors (TSLA)
Alphabet Opt Put Option (GOOG)
Visa Opt Put Option (V)
Broadcom Opt Call Option (AVGO)
Berkshire Hathaway (BRK.B)
JPMORGAN CHASE &amp Opt Put Option (JPM)

View all positions for Barclays

Top funds holding Oncolytics Biotech

Morgan Stanley
International Assets Investment Management
Citadel Advisors
Goldman Sachs Group
Commonwealth Equity Services
Royal Bank of Canada
CIBC World Markets
Geode Capital Management
Millennium Management
Long Focus Capital Management
Bank Of Montreal
Ausdal Financial Partners
Brave Asset Management
LPL Financial
C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors

View all funds holding Oncolytics Biotech